The senior author of the article entitled, “Ascorbic Acid Improves Embryonic Cardiomyoblast Cell Survival and Promotes Vascularization in Potential Myocardial Grafts In Vivo,” published in the April 2010 issue of Tissue Engineering Part A (vol. 16, no. 4, pages 1349–1361), contacted the editorial leadership of the Tissue Engineering journal to identify unintentional but significant duplication in figure 2 as well as magnification flaws in figure 7 within the published article.
Based on their reviews of the inaccuracies, the editors have decided to officially retract the paper from the literature.
Tissue Engineering
, its editors, and its publisher are committed to upholding the strictest standards of the scientific record and the community it serves.
Muller-EhmsenJ., WhittakerP., KlonerR.A., DowJ.S., SakodaT., LongT.I., LairdP.W., KedesL.Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol, 34, 107, 2002.
3.
SuzukiK., MurtuzaB., BeauchampJ.R., BrandN.J., BartonP.J., Varela-CarverA., FukushimaS., CoppenS.R., PartridgeT.A., YacoubM.H.Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation, 110, II219, 2004.
4.
TomaC., PittengerM.F., CahillK.S., ByrneB.J., KesslerP.D.Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93, 2002.
5.
RobeyT.E., SaigetM.K., ReineckeH., MurryC.E.Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol, 45, 567, 2008.
6.
FrangogiannisN.G.The immune system and cardiac repair. Pharmacol Res, 58, 88, 2008.
7.
BursacN., PapadakiM., CohenR.J., SchoenF.J., EisenbergS.R., CarrierR., Vunjak-NovakovicG., FreedL.E.Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol, 277, H433, 1999.
8.
CaspiO., LesmanA., BasevitchY., GepsteinA., ArbelG., HabibI.H., GepsteinL., LevenbergS.Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res, 100, 263, 2007.
9.
ArrigoniO., De TullioM.C.Ascorbic acid: much more than just an antioxidant. Biochim Biophys Acta, 1569, 1, 2002.
10.
VassilopoulosA., PapazafiriP.Attenuation of oxidative stress in HL-1 cardiomyocytes improves mitochondrial function and stabilizes Hif-1alpha. Free Radic Res, 39, 1273, 2005.
11.
FioritoC., RienzoM., CrimiE., RossielloR., BalestrieriM.L., CasamassimiA., MutoF., GrimaldiV., GiovaneA., FarzatiB., ManciniF.P., NapoliC.Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radic Res, 42, 754, 2008.
12.
TelangS., ClemA.L., EatonJ.W., ChesneyJ.Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model. Neoplasia, 9, 47, 2007.
13.
OmerogluS., PekerT., TurkozkanN., OmerogluH.High-dose vitamin C supplementation accelerates the Achilles tendon healing in healthy rats. Arch Orthop Trauma Surg, 2, 281, 2008.
14.
VissersM.C., GunninghamS.P., MorrisonM.J., DachsG.U., CurrieM.J.Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate. Free Radic Biol Med, 42, 765, 2007.
15.
ShindeR., PerkinsJ., ContagC.H.Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays. Biochemistry, 45, 11103, 2006.
16.
KutschkaI., ChenI.Y., KofidisT., AraiT., von DegenfeldG., SheikhA.Y., HendryS.L., PearlJ., HoytG., SistaR., YangP.C., BlauH.M., GambhirS.S., RobbinsR.C.Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation, 114, I167, 2006.
17.
HauckE.S., ZouS., ScarfoK., NantzM.H., HeckerJ.G.Whole animal in vivo imaging after transient, nonviral gene delivery to the rat central nervous system. Mol Ther, 16, 1857, 2008.
18.
CaoF., LinS., XieX., RayP., PatelM., ZhangX., DrukkerM., DyllaS.J., ConnollyA.J., ChenX., WeissmanI.L., GambhirS.S., WuJ.C.In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation, 113, 1005, 2006.
19.
LeorJ., Aboulafia-EtzionS., DarA., ShapiroL., BarbashI.M., BattlerA., GranotY., CohenS.Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?. Circulation, 102, III56, 2000.
20.
HodgesR.E., HoodJ., CanhamJ.E., SauberlichH.E., BakerE.M.Clinical manifestations of ascorbic acid deficiency in man. Am J Clin Nutr, 24, 432, 1971.
21.
ChenI.Y., GreveJ.M., GheysensO., WillmannJ.K., Rodriguez-PorcelM., ChuP., SheikhA.Y., FaraneshA.Z., PaulmuruganR., YangP.C., WuJ.C., GambhirS.S.Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imaging Biol, 11, 178, 2009.
22.
JenkinsD.E., OeiY., HornigY.S., YuS.F., DusichJ., PurchioT., ContagP.R.Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis, 20, 733, 2003.
23.
KangP.M., IzumoS.Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med, 9, 177, 2003.
24.
McClintockD.S., SantoreM.T., LeeV.Y., BrunelleJ., BudingerG.R., ZongW.X., ThompsonC.B., HayN., ChandelN.S.Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol, 22, 94, 2002.
25.
MalhotraR., TysonD.W., RosevearH.M., BrosiusF.C.III. Hypoxia-inducible factor-1alpha is a critical mediator of hypoxia induced apoptosis in cardiac H9c2 and kidney epithelial HK-2 cells. BMC Cardiovasc Disord, 8, 9, 2008.
26.
GrahamR.M., FrazierD.P., ThompsonJ.W., HalikoS., LiH., WasserlaufB.J., SpigaM.G., BishopricN.H., WebsterK.A.A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol, 207, 3189, 2004.
27.
HuangJ., AgusD.B., WinfreeC.J., KissS., MackW.J., McTaggartR.A., ChoudhriT.F., KimL.J., MoccoJ., PinskyD.J., FoxW.D., IsraelR.J., BoydT.A., GoldeD.W., ConnollyE.S.Jr.Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A, 98, 11720, 2001.
28.
KimE.J., WonR., SohnJ.H., ChungM.A., NamT.S., LeeH.J., LeeB.H.Anti-oxidant effect of ascorbic and dehydroascorbic acids in hippocampal slice culture. Biochem Biophys Res Commun, 366, 8, 2008.
29.
AsmisR., WintergerstE.S.Dehydroascorbic acid prevents apoptosis induced by oxidized low-density lipoprotein in human monocyte-derived macrophages. Eur J Biochem, 255, 147, 1998.
30.
GogouE., HatzoglouC., ChamosV., ZarogiannisS., GourgoulianisK.I., MolyvdasP.A.The contribution of ascorbic acid and dehydroascorbic acid to the protective role of pleura during inflammatory reactions. Med Hypotheses, 68, 860, 2007.
31.
MartinoL., NovelliM., MasiniM., ChimentiD., PiaggiS., MasielloP., De TataV.Dehydroascorbate protection against dioxin-induced toxicity in the beta-cell line INS-1E. Toxicol Lett, 189, 27, 2009.
32.
KcS., CarcamoJ.M., GoldeD.W.Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J, 19, 1657, 2005.
33.
PuskasF., GergelyP.Jr., BankiK., PerlA.Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J, 14, 1352, 2000.
